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The past decade has witnessed adoption of conservative gynecologic treatments, including
minimally invasive surgery (MIS), alongside steady declines in inpatient hysterectomies. It
remains unclear what factors have contributed to trends in outpatient benign hysterectomy
(BH), as well as whether these trends exacerbate disparities.
Materials and methods
Retrospective cohort of 527,964 women18 years old who underwent BH from 2008 to
2014. BH surgical approaches included: open/abdominal hysterectomy (AH), vaginal hys-
terectomy (VH), laparoscopic hysterectomy (LH), and robotic-assisted hysterectomy (RH).
Quarterly frequencies were calculated by care setting and surgical approach. We used mul-
tilevel logistic regression (MLR) using the most recent year of data (2014) to examine the
influence of patient-, physician-, and hospital-level preoperative factors and surgical
approaches on outpatient migration.
Results
From 2008–2014, surgical approaches for LH and RH increased, which coincided with
decreases in VH and AH. Overall, a 44.2% shift was observed from inpatient to outpatient
settings (P<0.0001). Among all outpatient visits MIS increased, particularly for RH (3.6% to
41.07%). We observed increases in the proportion of non-Hispanic Black and Medicaid
patients who obtained MIS in 2014 vs. 2008 (P<0.001). Surgical approach (51.8%) and phy-
sician outpatient MIS experience (19.9%) had the greatest influence on predicting outpatient
BH. Compared with LH, RH was associated with statistically significantly higher likelihood of
outpatient BH overall (OR 1.23; 95% CI, 1.16–1.31), as well as in sub-analyses of more
complex cases and hospitals that performed1 RH (P<0.05).
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Conclusion
From 2008–2014, rates of LH and RH significantly increased. A significant shift from inpa-
tient to outpatient setting was observed. These findings suggest that RH may facilitate the
shift to outpatient BH, particularly for patients with complexities. The adoption of MIS in out-
patient settings may improve access to disadvantaged patient groups.
Introduction
Hysterectomy is the most common procedure for women with benign gynecological conditions.
Adoption of conservative gynecologic treatments during the past decade, including minimally
invasive procedures, have occurred alongside steady declines in inpatient hysterectomies [1–3].
Minimally invasive surgery (MIS) approaches–including laparoscopic hysterectomy (LH), vagi-
nal hysterectomy (VH), and robotic-assisted hysterectomy (RH)–are becoming increasingly
common relative to abdominal hysterectomy (AH) even for complex cases, which is supported
by improvements in surgical equipment and emerging developments in specialized fellowship
training programs [4–5]. The benefits of MIS for benign hysterectomy (BH) have been clearly
documented [1–4]. Patients who have undergone MIS experience fewer medical and surgical
complications, better quality of life, and substantially lower medical costs overall [2, 5–11].
Major professional societies in gynecology now recommend MIS as a first line to avoid the mor-
bidity of laparotomy [1, 12]. LH and RH in the outpatient setting are generally considered safe
and feasible [5, 13–16]. Given the benefits of minimally invasive hysterectomy and the safety and
feasibility profile in an outpatient setting, private payers implemented prior authorization for
inpatient surgery starting in 2015 [17, 18]. Beginning in 2016, Centers for Medicare & Medicaid
Services (CMS) Medicare Part B Outpatient Prospective Payment System substantially increased
reimbursement rates for most BH procedures, providing further incentive for outpatient BH
[19].
According to two large database studies, AH was the most commonly performed surgical
approach for all BH cases and for inpatient BH by first quarter 2010 [20, 21]. However, these
studies were unable to capture the increasingly common outpatient hysterectomy. A recent
cross-sectional study of State Ambulatory Surgery and Services Databases from 16 states for
year 2011 estimated approximately 100,000–200,000 outpatient hysterectomies per year;
approximately 81.5% performed laparoscopically and 16% vaginally [22]. To our knowledge,
no previous study has examined trends in care setting over time. This is important because
one of the purported benefits of MIS is that it may enable more outpatient surgery.
Our objective in the present study was to examine trends in surgical approaches and care
settings among patients in the United States (US) who underwent BH from 2008–2014. We
conducted a nationwide analysis of hysterectomy trends stratified by inpatient and outpatient
settings using a large hospital administrative database of hospitals in the United States. The
influence of patient-, physician-, hospital-level preoperative factors, and surgical approaches
on patient pathway to inpatient vs. outpatient BH were also explored.
Materials and methods
Data and patients
The Premier Hospital Perspective1 Database (Premier) includes more than 700 hospitals that
cover more than 45 million inpatient visits and approximately 210 million outpatient visits
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from acute care facilities, ambulatory surgery centers, and clinics across the United States [23].
Women aged18 years who underwent BH from 2008 to 2014 were identified in the Premier
database. International Classification of Disease, version 9 (ICD-9) procedure codes were used
to identify surgical approaches, defined as BH [AH (68.3, 68.39, 68.4, 68.49, 68.9) VH; (68.59);
LH (68.31, 68.41, 68.51, V64.41), and RH (17.41, 17.42, 17.44, 17.49, or recorded charged code
for robotic instrumentation)]. We excluded 11.8% of women who underwent hysterectomy
with: a diagnosis of cancer (ICD-9 CM 179, 180.0, 180.1, 180.8, 180.9, 181, 182.0, 182.1, 182.8,
183.0, 183.2, 183.3, 183.4, 183.5, 183.8, 183.9, 184.0, 184.1, 184.2, 184.3, 184.4, 184.8, 184.9,
233.1, 233.2, 233.3, 233.31, 233.32, 233.39, 236.0, 236.1, 236.2, 236.3); pelvic or lower abdomi-
nal trauma (ICD-9 CM 867.4, 867.5, 867.6, 867.7, 867.8, 867.9, 868.00, 868.03, 868.04, 868.09,
868.10, 868.13, 868.14, 868.19, 869.0, 869.1, 879.6, 879.7, 879.8, 879.9, 906.0, 908.1, 908.2,
929.1, 947.4); pregnancy, childbirth, or location in the puerperium (Major diagnosis category
00014)(Fig 1).
Variables
Inpatient or outpatient BH was defined based on the outpatient/inpatient indicator in Premier
(S1 Table). Patients were classified as inpatient if admitted to a hospital, skilled nursing facili-
ties, or long-term care. Patients were classified as outpatients if they spent less than 24 hours in
the hospital after surgery, had same day, or ambulatory surgery.
Patient socio-demographic variables included age, race, and insurance type (Medicare,
Medicaid, commercial, or self-pay/others); patient clinical characteristics included Charlson
Comorbidity Index (CCI), uterine weight (250 g vs.>250 g), adhesion (including intra-
abdominal and vaginal), obesity (body mass index [BMI]30), indications for surgery
(fibroids, endometriosis, uterus bleeding, pelvic prolapse, or chronic pelvic pain) [20, 24], and
type of hysterectomy (total or subtotal). Race was included to explore any disparity in the
access to healthcare and/or advanced techniques.
The specialty information of physicians prefoming hysterectomy was provided from Pre-
mier and was defined as obstetrics and gynecology/OBGYN, gynecologic oncology/GYN
ONC, or others. Physician outpatient MIS experience was defined as if the physician had
Fig 1. Flow chart of study sample inclusion and exclusion criteria.
https://doi.org/10.1371/journal.pone.0188812.g001
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performed at least one outpatient BH through MIS (VH, LH, or RH) since January 1, 2008.
Hospital characteristics included location (rural or urban), hospital type (community or teach-
ing), region (Midwest, Northwest, South, or West), and bed size (<200, 200–400, 401–600, or
>600). Institutional Review Board (IRB) exemption was obtained from Western Institutional
Review Board documenting the analysis of data with no patient, provider, or hospital
identifiers.
Trend analysis
The proportions of the four surgical approaches performed for inpatient vs. outpatient BH
were calculated in each quarter. Trend analysis among outpatient BH were performed with
further examination of cases with2 complexities (defined as obesity [BMI30]), adhesions,
or uterine weight >250 g). Since not all hospitals have a robot for RH, the analysis was then
limited to hospitals that performed1 RH during 2008–2014, which was used as the proxy for
the measure of hospitals with robotic technology for BH. The rates of each surgical approach
were calculated by number of quarters after the introduction of RH at a given hospital.
Statistical analysis
The descriptive analysis of patient, physician, and hospital characteristics observed between
2008 and 2014 were determined by chi-square tests for categorical variables and t tests for con-
tinuous variables. Trends of each surgical approach within inpatient and outpatient visits were
reported. Ordinary least square regression was performed to assess the linear time trend across
quarters during the entire timeframe examined. The analyses of inpatients were weighted to
obtain nationally representative estimates [25]. No weight was available for the outpatient set-
ting and thus the analyses including outpatient cases were unweighted.
Multivariate logistic regression (MLR) analysis was conducted among women receiving BH
to assess the impact of patient, physician, and hospital preoperative factors as well as surgical
approach on the odds of the BH being performed in an outpatient vs. inpatient setting [26].
The MLR was conducted using the most recent year of data, 2014. Adjusted R-squared was
used for model diagnostics and reported for contributions of variation predicting the likeli-
hood of outpatient BH from different factors. Adjusted odds ratios (ORs) were used to esti-
mate the impact of surgical approach (AH, VH, LH, or RH) on the odds of outpatient BH,
using LH as the reference group. Subgroup analyses were conducted among patients with2
complexities and in hospitals having a robot for BH. Additional analysis was repeated using
2008 data to provide a reference for the trend analysis. All analyses were conducted with SAS
version 9.4 (SAS Institute, Cary, NC, USA).
Results
The descriptive characteristics for patients who had a BH in 2008 and 2014 are presented in
Table 1. In 2008, AH (44.5%) was the most common surgical approach, and RH was the least
common (2.8%). In 2014, LH (31.4%) became the leading surgical approach, followed by RH
(29.3%). In both 2008 and 2014, patient characteristics varied significantly across different
surgical approaches (all P<0.001). Specifically, compared to AH, more patients in the MIS
cohorts (ie, patients who underwent VH, LH, and RH) were white and were less likely to have
adhesions, obesity, or2 complexities (all P<0.0001). The indication of surgery also varied
across the four cohorts: AH had more patients with fibroids, and VH had more patients with
pelvic prolapse. When comparing changes in patient population between 2008 to 2014, more
black, Medicare or Medicare insured, and complex patients had MIS BH in 2014, and substan-
tially more RH procedures were done in nonteaching and in smaller bed size hospitals in 2014.
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Table 1. Patient characteristics for benign hysterectomy performed in 2008 and 2014.
Surgical Approach
2008 (n = 72,922) 2014 (n = 59,628)
AH VH LH RH P value AH VH LH RH P value
n (%) 32,479 (44.5) 15,327 (21.2) 23,059 (31.6) 2057 (2.8) 15,080 (25.3) 8367 (14.0) 18,700 (31.4) 17,841 (29.3)
Age, n (%), y <0.0001 <0.0001
<40 7760 (23.9) 3759 (24.5) 6986 (30.3) 451 (21.9) 2974 (19.7) 1759 (21.0) 5203 (27.8) 4308 (24.6)
40–44 7905 (24.3) 2857 (18.6) 5652 (24.5) 459 (22.2) 3498 (23.2) 1366 (16.3) 4651 (24.9) 3892 (22.3)
45–49 8551 (26.4) 2745 (17.9) 5489 (23.8) 546 (26.5) 4050 (26.9) 1272 (15.2) 4124 (22.1) 3797 (21.7)
50–54 4160 (12.8) 1615 (10.5) 2632 (11.4) 271 (13.2) 2242 (14.9) 837 (10.0) 2220 (11.9) 2276 (13.0)
55–60 1570 (4.8) 1067 (6.96) 982 (4.3) 129 (6.3) 876 (5.8) 716 (8.6) 965 (5.2) 1157 (6.6)
60 2533 (7.8) 3284 (21.4) 1318 (5.7) 204 (9.9) 1440 (9.6) 2417 (28.9) 1537 (8.2) 2051 (11.7)
Race, n (%) <0.0001 <0.0001
White 18,442 (56.8) 10,955 (71.4) 16,089 (69.8) 1476
(71.8)
7765 (51.5) 6205 (74.1) 13,455 (72.0) 12,279 (70.2)
Black 6670 (20.5) 955 (6.2) 2493 (10.8) 207 (10.1) 4157 (27.6) 670 (8.0) 2656 (14.2) 2578 (14.8)
Other 2270 (7.0) 907 (5.9) 848 (3.7) 143 (7.0) 4144 (20.9) 1488 (17.8) 2584 (13.8) 2614 (14.5)
Unknown 5090 (15.7) 2515 (16.4) 3629 (15.7) 231 (11.2) 14 (0.1) 4 (0.1) 11 (0.1) 10 (0.01)
Insurance type, n (%) <0.0001 <0.0001
Medicaid 2962 (9.1) 1212 (7.9) 1830 (7.9) 138 (6.7) 2548 (16.9) 1231 (14.7) 2599 (13.9) 1978 (11.3)
Medicare 2532 (7.8) 2432 (15.9) 1260 (5.5) 181 (8.9) 1485 (9.9) 1800 (21.6) 1497 (8.0) 1776 (10.2)
Self-pay/other 3186 (9.8) 1424 (9.3) 1883 (8.7) 132 (6.4) 1253 (8.3) 556 (6.7) 1564 (8.4) 1133 (6.5)
Commercial 23,799 (73.3) 10,259 (66.9) 18,086 (78.4) 1606
(78.7)
9794 (65.0) 4766 (57.0) 13,043 (69.8) 12,594 (72.0)
CCI, mean (SD) 0.31 (1.0) 0.19 (0.5) 0.19 (0.8) 0.28 (0.8) <0.0001 0.52 (1.2) 0.26 (0.6) 0.25 (0.7) 0.29 (0.7) <0.0001
Indication for surgery
Fibroids (Leiomyma & benign neoplasm) 22,133 (68.2) 5249(34.3) 12,282 (53.3) 1161 (56.4) <0.0001 11,001 (73.0) 2959(35.4) 10,387 (55.6) 10,100 (57.8) <0.0001
Endometriosis 8751 (26.9) 2728 (17.8) 7534 (32.7) 591 (28.7) <0.0001 2792 (18.5) 1880 (22.5) 6622 (35.4) 6221 (35.6) <0.0001
Pelvic prolapse 2229 (6.9) 8828 (57.6) 3371 (14.6) 175 (7.0) <0.0001 803 (5.3) 4916 (58.8) 2272 (12.2) 2194 (12.6) <0.0001
Uterus bleeding 16,240 (50.0) 6655 (43.4) 13,329 (57.8) 1023
(49.7)
<0.0001 7543 (50.0) 3255 (38.9) 10,480 (56.0) 8953 (51.2) <0.0001
Chronic pelvic pain 5937 (18.3) 1389 (9.1) 5109 (22.2) 376 (18.3) <0.0001 2709 (18.0) 922 (11.0) 4697 (25.1) 4216 (24.1) <0.0001
Complexities
Uterine size
>250 g, n (%)
827 (2.6) 470 (3.1) 1477 (6.4) 174 (8.5) <0.0001 739 (4.9) 567 (6.8) 2469 (13.2) 2676 (15.3) <0.0001
Adhesions, n (%) 7181 (22.1) 205 (1.3) 339 (14.7) 334 (16.2) <0.0001 2869 (19.0) 58 (0.7) 1947 (10.4) 2714 (12.1) <0.0001
Obesitya, n (%) 3924 (12.1) 917 (6.0) 1892 (8.2) 212 (10.3) <0.0001 2787 (18.5) 859 (10.3) 2485 (13.3) 2736 (15.7) <0.0001
2 complexities, n (%) 1320 (4.1) 61 (0.4) 625 (2.7) 77 (3.7) <0.0001 837 (5.6) 86 (1.0) 854 (4.6) 1031 (5.9) <0.0001
Type of BH, n (%) <0.0001 <0.0001
Subtotal 4030 (12.4) 15,324 (100.0) 19,238 (84.2) 1146 (57.0) 2618 (17.4) 8366 (100.0) 10,782 (58.12) 5119 (29.65)
Total 28,449 (87.6) 3 (0.02) 3610 (15.8) 1146 (43.0) 12,462 (82.6) 1 (0.01) 7768 (41.88) 12,145 (70.4)
Physician specialty <0.0001 <0.0001
OBGYN/GYN 29,529 (90.9) 14,603 (92.2) 21,586 (94.5) 1707 (83.9) 12,848 (85.2) 7550 (90.2) 16,476 (88.8) 14,974 (85.7)
Gynecological oncology 868 (2.7) 544 (3.6) 595 (2.6) 14 (0.7) 881 (5.9) 741 (8.9) 1284 (6.9) 1141 (6.5)
Other 2082 (6.4) 180 (1.2) 667 (2.9) 313 (15.4) 1223 (8.2) 76 (0.9) 790 (4.3) 1354 (7.8)
Physicians with outpatient MIS experience 2233 (6.9) 6490 (42.3) 10,674 (46.3) 1008 (51.8) <0.0001 5927 (39.3) 7235 (86.5) 15,916 (85.1) 16,447 (94.1) <0.0001
Location <0.0001 <0.0001
Rural 3485 (10.7) 2275 (14.9) 2596 (11.3) 298 (14.8) 2123 (14.1) 1829 (21.9) 2791 (14.50) 1701 (9.7)
Urban 28,994 (89.3) 13,052 (85.1) 20,463 (88.7) 1759 (85.2) 12,935 (85.9) 6518 (78.9) 15,830 (85.0) 15,773 (90.3)
Region <0.0001 <0.0001
Midwest 5891 (18.1) 3467 (22.6) 4479 (19.3) 594 (28.9) 2832 (18.8) 1481 (17.7) 2936 (15.8) 3545 (20.3)
Northeast 4411 (13.6) 1456 (9.5) 2381 (10.3) 260 (12.6) 2725 (18.1) 1071 (12.8) 2173 (11.7) 1971 (11.3)
South 16,887 (52.0) 6391 (41.8) 11,439(49.4) 884 (43.0) 7774 (51.6) 4257 (51.0) 11,047 (59.3) 9908 (56.7)
West 5290 (16.3) 4013 (26.2) 4760 (20.6) 319 (15.5) 1727 (11.5) 1538 (18.4) 2465 (13.2) 2050 (11.7)
Teaching hospital <0.0001 <0.0001
No 21,493 (66.2) 10,813 (70.6) 15,427 (66.9) 1202 (58.4) 8861 (58.9) 5077 (60.8) 12,298 (66.0) 11,375 (65.1)
Yes 10,986 (33.8) 4514 (29.5) 7632 (33.1) 855 (41.6) 6197 (41.5) 3270(39.2) 6323 (34.0) 6099 (34.9)
Bed count <0.0001 <0.0001
<200 4833 (14.9) 2752 (18.0) 4672 (20.1) 186 (9.0) 2714 (18.0) 1794 (21.4) 5025 (26.9) 2591 (14.8)
201–400 13,242 (40.8) 6036 (39.4) 8183 (35.5) 561 (27.3) 6011 (39.9) 3321 (39.7) 6617 (35.4) 7490 (42.9)
(Continued)
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Notably, by analyzing different types of hospitals, both procedure volume and proportion of
VH declined substantially among nonteaching hospitals, regardless of bed size.
From the first quarter (Q1) of 2008 to the last quarter (Q4) of 2014, RH and LH approaches
increased (1.7% to 29.3% and 29.4% to 31.2%, respectively), which coincided with decreases in
VH and AH (21.2% to 13.5% and 47.8% to 25.9%, respectively; P<0.0001; Fig 2A). A statisti-
cally significant shift from the inpatient to the outpatient setting was observed; 13.3% of BH
were performed as outpatient procedures in 2008 vs. 57.5% in 2014 (P<0.0001;Fig 2B; Fig 2C).
Among outpatient procedures performed from Q1 2008 to Q4 2014, RH increased from 3.6%
to 41.1%, while AH decreased from 2.6% to 0.9%. LH decreased from 69.0% to 42.2%, and VH
decreased from 24.8% to 15.8% (S1 Fig; S2 Table). For outpatient surgeries with2 complexi-
ties, RH increased from 10.9% to 53.0%, and LH decreased from 78.3% to 42.6% (S2 Fig).
The MLR analysis revealed that in predicting outpatient BH in 2014, patient-level factors
contributed 58.99%, surgeon-level factors 20.85%, and hospital-level factors 7.18% (Table 2).
Surgical approach (51.84%) and surgeon MIS experience (19.92%) in the outpatient setting
were the top two individual contributing factors. Among patient-level factors, subtotal hyster-
ectomy was associated with increased likelihood of outpatient BH; being older, nonwhite,
obese, insured by Medicaid, or with a higher CCI was associated with decreased likelihood of
outpatient BH (S3 Table). Surgeon with experience in outpatient MIS, OBGYN surgeon, and
hospitals in the South region were associated with increased likelihoods of outpatient BH.
With regard to the effect of surgical approach (Table 3), compared with the reference group
of LH, RH was associated with a modestly increased odds of outpatient BH (OR 1.23; 95% CI,
1.16–1.31). In those patients with complexities, RH was associated with an increased odds of
outpatient BH, particularly among patients with adhesions (OR 1.74; 95% CI, 1.49–2.04).
Compared to AH, strongly increased odds of outpatient MIS were observed for VH (OR 80.52;
95% CI, 70.29–92.24), LH (OR 111.38; 95% CI, 98.91–125.56), and RH (OR 137.27; 95% CI,
121.69–154.85).
Stratifying the data for robotic BH hospitals, similar patterns were found (Table 3). In this
subgroup of hospitals, the odds of outpatient BH for RH vs. LH was similar to that observed
for all hospitals. The analysis of 2008 data shows similar results (S4 Table).
Discussion
The present study provides the first nationwide analysis of trends for BH stratified by setting
and surgical approach. The analyses of the changing trends of surgical approaches in benign
hysterectomy–overall, in inpatient and outpatient settings, and among those complex
Table 1. (Continued)
Surgical Approach
2008 (n = 72,922) 2014 (n = 59,628)
AH VH LH RH P
value


























aBMI30. AH, open/abdominal hysterectomy; BH, benign hysterectomy; BMI, body mass index; CCI, Charlson Comorbidity Index; LH, laparoscopic
hysterectomy; MIS, minimally invasive surgery; OBGYN, obstetrics and gynecology; RH, robotic hysterectomy; SD, standard deviation; VH, vaginal
hysterectomy, y, year.
https://doi.org/10.1371/journal.pone.0188812.t001
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Fig 2. Trends for BH from Q1 2008 through Q4 2014. (A) All Visits by Surgical Approach, (B) All Visits by Care Setting, and (C) All Visits by
Surgical Approach and Care Setting, 2008 and 2014 only. BH, benign hysterectomy; RH, robotic hysterectomy; y, year.
https://doi.org/10.1371/journal.pone.0188812.g002
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patients–were descriptive. The results demonstrate that from 2008–2014 care setting for BH
significantly shifted from inpatient to outpatient, paralleled by the substantial increase of MIS.
We further performed a multivariate logistic regression to analyze the contribution or likeli-
hood of in vs. outpatients, by which we confirmed that after controlling other factors, surgical
approach of MIS, in particular robotic, increases the likelihood of outpatient surgery. Surgical
approach and physician outpatient MIS experience were the top two factors that predicted a
patient having an outpatient BH. Investigating the various impacts within different surgical
approaches, RH is associated with an increased odds of outpatient BH in all hospitals and in
hospitals with RH technology, and the odds are greater in patients with complex BH proce-
dures. This suggests that outpatient migration may reduce disparities, improving access to dis-
advantaged patient groups and in non-teaching hospitals. Moreover, our analyses of the odds
of outpatient surgery suggest that MIS adoption and outpatient migration may be associated.
The landscape of BH has changed dramatically in the past decade with more outpatient BH
and more MIS procedures being performed. Our findings suggest that BH significantly shifted
from inpatient to outpatient, with 13.3% of all hysterectomies performed as an outpatient pro-
cedure in 2008 vs. 57.5% in 2014; and the shift to outpatient BH was paralleled with a substan-
tial increase of MIS, including LH and RH. When looking solely at the inpatient setting, AH
was still the most common approach, which is consistent with nationwide-based studies based
exclusively on inpatient settings [20, 21]. However, when taking into account both the inpa-
tient and outpatient settings, AH was no longer the predominant procedure, dropping from
49.5% in Q1 2008 to 28.1% in Q4 2014. These findings were consistent with previous reports
comparing hysterectomy trends in earlier time periods [21, 27–29].
Table 2. Contributions of hospital, surgeon, and patient characteristics to the variation in predicting likelihood of outpatient BH, 2014.
All Obese Population Adhesion Population Uterine Weight >250 g Population
Variation %
Full model 63.11 66.45 63.20 71.59
Patient Characteristics 58.99 61.91 57.21 69.37
Social-demographic 5.21 5.91 4.75 3.33
Surgical approach 51.84 52.85 49.61 63.93
CCI 1.14 1.32 0.89 0.63
Complexity 9.16 11.01 6.16 3.84
Obesity 0.74 N/A 0.69 0.88
Adhesion 3.59 4.31 N/A 3.14
Uterus weight 5.18 6.76 5.40 N/A
Indication of surgery 8.44 10.50 6.51 8.22
Fibroids 0.45 0.38 0.24 4.28
Endometriosis 6.49 8.88 3.85 3.11
Pelvic prolapse 0.06 0.00 0.12 0.00
Uterus bleeding 0.32 0.59 0.17 0.37
Chronic pelvic pain 1.59 1.54 2.87 0.00
Total/Subtotal hysterectomy 4.71 3.54 4.42 6.28
Physician characteristics 20.85 22.88 23.4 22.22
Specialty 1.48 1.81 3.9 0.21
Physician experience of outpatient MIS 19.92 21.64 19.89 21.79
Hospital characteristics 7.18 8.19 9.63 8.51
BH, benign hysterectomy; CCI, Charlson Comorbidity Index; MIS, minimally invasive surgery.
https://doi.org/10.1371/journal.pone.0188812.t002
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The uptake of MIS in outpatient BH likely stems from a variety of factors, including:
improved patient outcomes through less invasive approaches; MIS training and awareness in
gynecologic societies; and more advanced technology, which could allow for the shift of more
complex BH to outpatient setting. Our analysis included data from 2008 to 2014, a timeframe
in which benefits of MIS have been clearly established, likely resulting from the routine perfor-
mance of and specialized training in MIS [6, 27, 30, 31]. As a result, the proportions of LH and
RH both increased. In particular, since approved for gynecology in 2005 [32], RH has become
significantly more widespread in both inpatient and outpatient settings and across different
hospital types. Although only 1.7% of all hysterectomies performed in Q1 2008 were RH, RH
accounted for 29.3% in Q4 2014. LH also increased from 29.4% to 31.2%. When looking only
at outpatient cases, the volumes of LH and RH both increased; however, the proportion of LH
decreased, which was paralleled with an increase in the proportion of RH over the study
period. Similarly, among outpatient BH cases with2 complexities, the proportion of RH
increased while the proportion of LH decreased. This indicates that RH may facilitate the out-
patient migration through becoming a valuable resource for complex surgical candidates,
allowing them access to the benefits of MIS, for which inpatient AH would be the only choice
otherwise. Given that RH has a similar safety profile as LH and VH and better outcomes than
AH [1, 3, 4, 8, 11], this shift toward RH may decrease overall morbidity and improve the safety
profile of hysterectomy by minimizing the use of AH, enabling more MIS in general, and
enabling complex MIS gynecologic procedures in the outpatient setting.
The findings from the trend analyses were supported by the MLR results. When consider-
ing all preoperative factors, RH was significantly associated with an increased odds of
Table 3. Estimated effects of surgical approaches on the likelihood of outpatient BH, 2014 (N = 59,628).
OR (95% CI) All Population* Obese† (BMI30) Adhesions‡ Uterine Weight
>250 g§
All hospitals VH vs. AH 80.52 (70.29–92.24) 89.29 (60.79–131.14) 31.82 (15.41–65.70) 303.16 (160.58–572.33)
LH vs. AH 111.38 (98.91–125.56) 108.56 (78.13–150.84) 69.31 (48.06–99.95) 575.56 (339.16–976.37)
RH vs. AH 137.27 (121.69–154.85) 136.99 (98.58–190.38) 120.75 (83.62–174.37) 606.34 (358.23->999.99)
RH vs. LH 1.23 (1.16–1.31) 1.26 (1.09–1.47) 1.74 (1.49–2.04) 1.05 (0.79–1.40)
Robotic BH hospital VH vs. AH 74.16 (63.49–86.62) 105.63 (65.91–169.29) 20.94 (8.16–53.70) 233.31 (110.75–491.52)
LH vs. AH 104.58 (91.11–120.05) 118.51 (78.20–179.59) 61.81 (40.87–93.47) 423.14 (229.96–778.61)
RH vs. AH 129.27 (112.77–148.19) 160.28 (106.25–241.79) 104.57 (69.40–157.56) 632.74 (346.17->999.99)
RH vs. LH 1.24 (1.16–1.32) 1.35 (1.15–1.60) 1.69 (1.42–2.02) 1.50 (1.08–2.08)
AH, open/abdominal hysterectomy; BH, benign hysterectomy; BMI, body mass index; CI, confidence interval; g, grams; LH, laparoscopic hysterectomy;
OR, odds ratio; RH, robotic hysterectomy; Robotic BH hospital, hospitals with a robot for BH in 2014; VH, vaginal hysterectomy.
*Adjusted for age, race, insurance type, hysterectomy type (total/subtotal), Charlson comorbidity score, indication for surgery (fibroids, endometriosis,
pelvic prolapse, uterus bleeding, and chronic pelvic pain), obese, uterine weight (>250 g vs.250 g), physician specialty, teaching, hospital region, hospital
area (urban/rural), bed size.
†Adjusted for age, race, insurance type, hysterectomy type (total/subtotal), Charlson comorbidity score, indication for surgery (fibroids, endometriosis,
pelvic prolapse, uterus bleeding, and chronic pelvic pain), adhesion, uterine weight (>250 g vs.250 g), physician speciality, physician experience of
outpatient minimally invasive surgery, teaching, hospital region, hospital area (urban/rural), bed size.
‡Adjusted for age, race, insurance type, hysterectomy type (total/subtotal), Charlson comorbidity score, indcation for surgery (fibroids, endometriosis, pelvic
prolapse, uterus bleeding, and chronic pelvic pain), obese, uterine weight (>250 g vs.250 g), physician speciality, physician experience of outpatient
minimally invasive surgery, teaching, hospital region, hospital area (urban/rural), bed size.
§Adjusted for age, race, insurance type, hysterectomy type (total/subtotal), Charlson comorbidity score, indication for surgery (fibroids, endometriosis,
pelvic prolapse, uterus bleeding, and chronic pelvic pain), obese, adhesion, physician speciality, physician experience of outpatient minimally invasive
surgery, teaching, hospital region, hospital area (urban/rural), bed size.
https://doi.org/10.1371/journal.pone.0188812.t003
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outpatient BH compared to LH. Overall, the odds were greater for patients with complexities
and were greatest for such patients in hospitals with robotic technology. Interestingly, across
all subgroups, VH was associated with a decreased odds of an outpatient procedure. Addition-
ally, the substantial decrease of VH, particularly in nonteaching hospitals, suggests that there
may be real-world challenges for the utilization of VH, despite recommendations from profes-
sional societies [33].
There may be a concern that the implementation of a new technology may be accessible
only to certain patient groups, which may acerbate health disparities. This study suggests that
racial disparities and socioeconomic barriers in access to LH and RH may exist. In 2014,
whites were more likely to have MIS, whereas blacks were more likely to have AH. Commer-
cially insured patients were more likely to have LH or RH, while patients with Medicaid or
Medicare insurance were more likely to have AH or VH. However, when compared to the
2008 data, a substantially increased volume and proportion of black and Medicaid or Medicare
insured patients had access to LH or RH in 2014. In particular for RH, the volume increase in
the health disadvantaged groups was greater for RH than for LH. Further, RH use increased
substantially in nonteaching and in smaller bed size hospitals. These data suggest that the
adoption of RH, or MIS in general, did not acerbate disparity and access to MIS. Rather, it
may improve the access of MIS in disadvantaged patient groups and in nonteaching hospitals.
This also further explains the trend of outpatient migration of BH from 2008–2014, as RH is
available and accessible to more patients in more places.
Multiple studies comparing RH to LH, AH, and VH found comparable clinical outcomes
yet cost advantages to nonrobotic approaches [4, 8, 34, 35]. However, since very few AH were
conducted in an outpatient setting, previous studies were often restricted to inpatient settings
[20, 21], this assured a fair comparison between AH and other surgical approaches but failed
to assess the clinical and economic benefits of MIS in an outpatient setting. The benefits of
enabling outpatient BH deserve further research and need to be considered in the cost-effec-
tiveness evaluation of surgical approaches for BH. Secondly, patients’ complexity and surgeon
experiences can affect outcomes [36–39], yet it is challenging to control for these factors in
outcome comparisons. As indicated in this study, patient characteristics vary substantially
among different surgical approaches. A study comparing RH to the other approaches found
that patients who underwent RH had more complexities (ie, were older, had higher rates of
adhesive disease, and large uteri) [2]. Our results further suggest that different surgical
approaches serve different patient populations. Hence, additional research is needed to clarify
the clinical and surgical complexity of BH patients and to identify the appropriate surgical
approach for specific patients under a particular setting.
Potential indications of open surgery versus MIS currently depend largely on the complex-
ity of the pateitn case, the experience and training of the surgeon, as well as the institutional
stand of care. To our knowledge, there are no current clear guidelines to triage for these com-
plex cases. Our results help to elucidate physician and institutional factors that differ for these
complex cases in the current US clinical environment. Our paper shows the trends of outpa-
tient benign hysterectomy in the current American healthcare system. The findings from our
study may help guide international communities by describing US trends– especially that cost
containment is a global theme and outpatient migration of a high volume procedure like
benign hysterectomy may help save cost from a societal perspective.
This study has several limitations. First, the study used the Premier database, where the out-
patient visits were unweighted. Thus, nationwide estimates–rather than population-based esti-
mates–were presented for outpatient trends. However, since it includes both inpatient and
outpatient records, the migration trend can be evaluated within the same database. Second,
our analyses relied on administrative codes in the database. During early adoption years, some
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hospitals may have coded RH as LH, failing to utilize the dedicated RH code. Other coding
limitations may exist, e.g., the complex cases and indication for surgery were based upon ICD-
9 and/or CPT codes rather than physician’s actual justifications. Third, the data were stratified
based upon selected complexities due to the lack of a standardized surgical complexity metric.
Future studies could investigate a composite complexity score, containing a broader spectrum
of weighted complexity indicators, so that the impact of complexity on outpatient migration
can be better evaluated. Fourth, our characterization of hospitals with RH technology may be
subject to biases due to factors at the facility level or catchment area level. Additional work
may inform factors contributing to adoption of MIS techniques, including adoption of RH.
Finally, the regression analysis focused on pre-operative factors; it thus did not include all pos-
sible variables such as intra-operative factors and concomitant procedures, which may be of
interest but are beyond the scope of this study. Finally, including the complications following
MIS, AH, and VH would have been an improvement; however Premier only could trace
patients within one hospital. The short-term perioperative and long-term complications after
surgery could be not fully captured in the Premier. Complications following benign hysterec-
tomy by techniques and care of settings are the subject of further research.
Conclusions
A shift in setting for BH from inpatient to outpatient was observed from 2008–2014. In outpa-
tient settings, statistically significant increases in MIS, especially the increase of RH in overall
and complex cases, were observed. Utilization of RH as the surgical approach was associated
with an increased odds of outpatient BH, particularly for patients with adhesions. Further
comprehensive cost-effectiveness analysis of BH surgical approaches incorporating patient
pathway of inpatient and outpatient setting and real-world comparative effectiveness of surgi-
cal outcomes is warranted. Further, the adoption of MIS in outpatient settings may improve
access to disadvantaged patient groups.
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